Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($0.49), versus ($0.51) reported last year. Revenue for the quarter came in at $10.43 million, versus $7.47 million reported last year.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.